Newsletter
Fluvoxamine for Outpatients With Mild to Moderate COVID-19, Accuracy of Stroke Risk Prediction Models, Organization and Performance of US Health Systems, and more

JAMA Editor’s Summary

Fluvoxamine for Outpatients With Mild to Moderate COVID-19, Accuracy of Stroke Risk Prediction Models, Organization and Performance of US Health Systems, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 24/31, 2023, issue. Related Content:
January 24, 2023

Fluvoxamine for Outpatients With Mild to Moderate COVID-19, Accuracy of Stroke Risk Prediction Models, Organization and Performance of US Health Systems, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 24/31, 2023, issue. Related Content:

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp